New drug cocktail targets tough esophageal cancer
NCT ID NCT07697040
First seen Jul 10, 2026 · Last updated Jul 10, 2026
Summary
This trial tests a new drug called becotatug vedotin, given together with standard chemotherapy (cisplatin) and radiation, for people with a type of advanced esophageal cancer. The main goals are to find the safest dose and see how well the combination works. About 12 participants will take part in this early-stage study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Becotatug vedotin (a drug that targets cancer cells) combined with cisplatin (chemotherapy) and radiation therapy
- What this could lead to
- If successful, this combination could offer a new treatment option for people with advanced esophageal cancer that hasn't spread widely.
- What could go wrong
- This is an early-phase trial with only 12 participants, so results may not apply to everyone. The drug combination may cause significant side effects, and it's too early to know if it works better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single Protein's mutations predict esophageal cancer outcomes?
- A sponge you swallow could detect esophageal cancer before it spreads
- Could a genetic marker guide future cancer therapies in taiwan?
- Could a lighter immunotherapy schedule keep advanced cancers in check?
- New drug cocktail aims to shrink Hard-to-Treat esophageal tumors
- Smart T-Cell engager aims to outsmart tumors in first human test